Literature DB >> 23598376

Emergence of daptomycin-non-susceptible enterococci urinary tract isolates.

Theodoros Kelesidis1, Romney Humphries2, Angela L P Chow3,4, Sotirios Tsiodras5, Daniel Z Uslan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23598376      PMCID： PMC8482838          DOI： 10.1099/jmm.0.056630-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN： 0022-2615            Impact factor:   3.196


× No keyword cloud information.
  9 in total

1.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.

Authors:  Teresa C Horan; Mary Andrus; Margaret A Dudeck
Journal:  Am J Infect Control       Date:  2008-06       Impact factor: 2.918

2.  Effectiveness of low-dose daptomycin in the treatment of vancomycin-resistant enterococcal urinary tract infections.

Authors:  Larry Fisher; Donald North
Journal:  Int J Antimicrob Agents       Date:  2009-01-18       Impact factor: 5.283

3.  Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of "clearance".

Authors:  L R Baden; W Thiemke; A Skolnik; R Chambers; J Strymish; H S Gold; R C Moellering; G M Eliopoulos
Journal:  Clin Infect Dis       Date:  2001-10-10       Impact factor: 9.079

4.  Contamination rates and antimicrobial resistance in bacteria isolated from "grass-fed" labeled beef products.

Authors:  Jiayi Zhang; Samantha K Wall; Li Xu; Paul D Ebner
Journal:  Foodborne Pathog Dis       Date:  2010-07-10       Impact factor: 3.171

5.  Characterization of antimicrobial resistance and virulence genes in Enterococcus spp. isolated from retail meats in Alberta, Canada.

Authors:  Mueen Aslam; Moussa S Diarra; Sylvia Checkley; Valerie Bohaychuk; Luke Masson
Journal:  Int J Food Microbiol       Date:  2012-03-29       Impact factor: 5.277

6.  De novo daptomycin-nonsusceptible enterococcal infections.

Authors:  Theodoros Kelesidis; Romney Humphries; Daniel Z Uslan; David Pegues
Journal:  Emerg Infect Dis       Date:  2012-04       Impact factor: 16.126

7.  Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians.

Authors:  Theodoros Kelesidis; Romney Humphries; Daniel Z Uslan; David A Pegues
Journal:  Clin Infect Dis       Date:  2011-01-15       Impact factor: 20.999

8.  Case-control study comparing de novo and daptomycin-exposed daptomycin-nonsusceptible Enterococcus infections.

Authors:  Theodoros Kelesidis; Angela L P Chow; Romney Humphries; Daniel Z Uslan; David Pegues
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.938

9.  Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus.

Authors:  Jeremy C Storm; Daniel J Diekema; Jennifer S Kroeger; Sarah J Johnson; Birgir Johannsson
Journal:  Antimicrob Resist Infect Control       Date:  2012-05-29       Impact factor: 4.887
  9 in total
  2 in total

1.  In vitro activity of daptomycin in combination with β-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci.

Authors:  Janet A Hindler; Annie Wong-Beringer; Carmen L Charlton; Shelley A Miller; Theodoros Kelesidis; Marissa Carvalho; George Sakoulas; Poochit Nonejuie; Joseph Pogliano; Victor Nizet; Romney Humphries
Journal:  Antimicrob Agents Chemother       Date:  2015-05-11       Impact factor: 5.191

Review 2.  The zoonotic potential of daptomycin non-susceptible enterococci.

Authors:  T Kelesidis
Journal:  Zoonoses Public Health       Date:  2013-11-26       Impact factor: 2.954
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.